Status: current, estado de definición: concepto suficientemente definido. Date: 31-Jul 2018. Module: módulo identificador del núcleo de la terminología de SNOMED CT (metadato del núcleo)
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | es un[a] | producto que contiene eritromicina y tretinoína en forma farmacéutica para administración cutánea como únicos ingredientes (forma farmacéutica de producto medicinal) | true | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | adopta un rol | rol terapéutico antibacteriano | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has concentration strength numerator unit | milligram (qualifier value) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has precise active ingredient | Erythromycin (substance) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | tiene base de sustancia de la potencia | Tretinoin (substance) | true | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | tiene base de sustancia de la potencia | Erythromycin (substance) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has concentration strength numerator unit | microgram (qualifier value) | true | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has precise active ingredient | Tretinoin (substance) | true | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | es un[a] | Product containing erythromycin in topical dosage form (medicinal product form) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | es un[a] | producto con tretinoína | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | tiene ingrediente activo (atributo) | Erythromycin (substance) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | tiene ingrediente activo (atributo) | Skin agent (substance) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | tiene ingrediente activo (atributo) | Tretinoin (substance) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | es un[a] | producto con eritromicina y tretinoína | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | tiene ingrediente activo (atributo) | Bactericide | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has manufactured dose form | Drug solution | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has manufactured dose form | Cutaneous solution | true | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | es un[a] | Product containing tretinoin in topical dosage form (medicinal product form) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has concentration strength denominator unit | gramo (calificador) | true | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has concentration strength numerator value (attribute) | 250 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | tiene base de sustancia de la potencia | Tretinoin (substance) | false | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Count of base of active ingredient | 2 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has concentration strength denominator value | 1 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has precise active ingredient | Erythromycin (substance) | false | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has concentration strength numerator unit | milligram (qualifier value) | false | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has concentration strength denominator value | 1 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has concentration strength numerator value (attribute) | 40 (calificador) | false | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has concentration strength numerator unit | microgram (qualifier value) | false | relación inferida | restricción existencial (metadato del núcleo) | 1 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has concentration strength denominator unit | gramo (calificador) | true | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | tiene base de sustancia de la potencia | Erythromycin (substance) | false | relación inferida | restricción existencial (metadato del núcleo) | 2 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has precise active ingredient | Tretinoin (substance) | false | relación inferida | restricción existencial (metadato del núcleo) | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets